| Literature DB >> 28417942 |
Zi-Wen Teng1, Shi-Jiao Xiong2, Gang Xu3, Shi-Yu Gan4, Xuan Chen5, David Stanley6, Zhi-Chao Yan7, Gong-Yin Ye8, Qi Fang9.
Abstract
Many species of endoparasitoid wasps provide biological control services in agroecosystems. Although there is a great deal of information on the ecology and physiology of host/parasitoid interactions, relatively little is known about the protein composition of venom and how specific venom proteins influence physiological systems within host insects. This is a crucial gap in our knowledge because venom proteins act in modulating host physiology in ways that favor parasitoid development. Here, we identified 37 possible venom proteins from the polydnavirus-carrying endoparasitoid Cotesia chilonis by combining transcriptomic and proteomic analyses. The most abundant proteins were hydrolases, such as proteases, peptidases, esterases, glycosyl hydrolase, and endonucleases. Some components are classical parasitoid venom proteins with known functions, including extracellular superoxide dismutase 3, serine protease inhibitor and calreticulin. The venom contains novel proteins, not recorded from any other parasitoid species, including tolloid-like proteins, chitooligosaccharidolytic β-N-acetylglucosaminidase, FK506-binding protein 14, corticotropin-releasing factor-binding protein and vascular endothelial growth factor receptor 2. These new data generate hypotheses and provide a platform for functional analysis of venom components.Entities:
Keywords: hosts; parasitoid wasps; proteomics; transcriptomics; venom gland; venom proteins
Mesh:
Substances:
Year: 2017 PMID: 28417942 PMCID: PMC5408209 DOI: 10.3390/toxins9040135
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Summary statistics of the analysis of the Cotesia chilonis venom gland and female adult carcass reads.
| Transcripts/Unigenes | Raw Reads | Clean Reads | No. of Transcripts/Unigenes | N50 | Meanlength | ||
|---|---|---|---|---|---|---|---|
| Venom Gland | Female Adult Carcass | Venom Gland | Female Adult Carcass | - | - | - | |
| Transcripts | 67,097,344 | 63,686,328 | 65,515,114 | 62,221,866 | 115,957 | 2393 | 1254 |
| Unigenes | 71,617 | 1309 | 759 | ||||
Functional characterization of up regulated unigenes from Cotesia chilonis venom gland.
| GO_Accession | Description | # Unigenes | Percentages * |
|---|---|---|---|
| GO:0003735 | Structural constituent of ribosome | 37 | 13.3 |
| GO:0004553 | Hydrolase activity, hydrolyzing | 14 | 5.0 |
| GO:0004620 | Phospholipase activity | 7 | 2.5 |
| GO:0004629 | Phospholipase C activity | 6 | 2.2 |
| GO:0005198 | Structural molecule activity | 42 | 15.1 |
| GO:0008233 | Peptidase activity | 30 | 10.8 |
| GO:0008237 | Metallopeptidase activity | 15 | 5.4 |
| GO:0016798 | Hydrolase activity, acting on glycosyl bonds | 14 | 5.0 |
| GO:0046982 | Protein heterodimerization activity | 3 | 1.1 |
* Percent values show the percent of upregulated VG unigenes (UVG).
Figure 1SDS-PAGE analysis of Cotesia chilonis venom proteins. Proteins were separated on a 12% SDS-PAGE gel and stained with Coomassie Brilliant Blue R-250. The left lane shows molecular weight markers and the right lane shows the venom proteins. The gel was cut into seven large sections, indicated by the red boxes. Tryptic peptides extracted from each section were excised and analysed on LC-MS/MS.
Figure 2Venn diagram illustrating a likely set of venom proteins. The diagram shows the intersection of UVG unigenes and those matched to the proteomic databases (VP). The numbers in the green and red ellipses represent the numbers of unigenes with complete sequences encoding secreted (green; S) or not secreted proteins (red; NS). The numbers in blue rectangle correspond to the numbers of proteins considered “possible venom proteins” [1,45].
Proteins recorded from Cotesia chilonis venom.
| Protein Name | RPKM/UniquePepCount | Putative Function | Sequence Length (Signal Peptide) | Blast Information (E-Value; Genbank No.; Species) | Gene ID | Accession No. |
|---|---|---|---|---|---|---|
| Cc-Ven1 | 106.52 (M)/2 | Serine protease | 390 (Y) | 2e−130; NP_001155078.1; | comp32062_c0 | KU663618 |
| Cc-Ven2 | 47.99 (L)/9 | Disintegrin and Metalloproteinase with thrombospondin motifs | 509 (Y) | 1e−58; EGI57486.1; | comp35977_c0 | KU663619 |
| Cc-Ven3 | 212.13 (M)/11 | Tolloid-like protein | 478 (Y) | 1.00e−94; XP_003695260.2; | comp35892_c0 | KU663620 |
| Cc-Ven4 | 219.32 (M)/30 | Tolloid-like protein | 477 (Y) | 7.00e−124; P_003695260.2; | comp39295_c0 | KU663621 |
| Cc-Ven5 | 1665.96 (H)/18 | Retinoid-inducible serine carboxypeptidase-like | 415 (Y) | 5.00e−71; XP_001605442.1; | comp11050_c0 | KU663622 |
| Cc-Ven6 | 261.11 (M)/1 | Aminopeptidase N-like | 148 (NC) | 3.00e−41; EFN65598.1; | comp43465_c0 | KU663623 |
| Cc-Ven7 | 4876.97 (H)/9 | 1-phosphatidyl inositol phosphodiesterase precursor | 230 (NC) | 6.00e−10; XP 007809166.1; | comp44319_c0 | KU663624 |
| Cc-Ven8 | 1010.49 (H)/30 | Phosphatidylinositol-specific phospholipase | 323 (Y) | 4.00e−52; EZA44899.1; | comp43453_c0 | KU663625 |
| Cc-Ven9 | 7010.08 (H)/29 | Phosphatidylinositol-specific phospholipase | 323 (Y) | 2.00e−55; EZA44899.1; | comp43453_c1 | KU663626 |
| Cc-Ven10 | 194.85 (M)/9 | Phospholipase A1 | 295 (Y) | 1.00e−54; EGI61859.1; | comp11611_c0 | KU663627 |
| Cc-Ven11 | 427.00 (M)/14 | Phospholipase A1 | 313 (Y) | 6.00e−89; XP 011258702.1; | comp35865_c0 | KU663628 |
| Cc-Ven12 | 437.68 (M)/35 | Chitooligosaccharidolytic β- | 603 (Y) | 0; XP_008213962.1; | comp35842_c0 | KU663629 |
| Cc-Ven13 | 24.39 (L)/1 | Enzymatic polyprotein Endonuclease; Reverse transcriptase | 1660 (NC) | 1e−126; XP 002431503.1; | comp43476_c1 | KU663630 |
| Cc-Ven14 | 202.99 (M)/12 | FK506-binding protein 14 | 239 (Y) | 6e−105; NP_476973.1; | comp12229_c0 | KU663631 |
| Cc-Ven15 | 203.89 (M)/14 | Protein disulfide-isomerase | 2002 (Y) | 0; XP_001602967.1; | comp32146_c0 | - |
| Cc-Ven16 | 412.07 (M)/1 | Protein disulfide-isomerase | 3554 (Y) | 8e−167; XP_011138070.1; | comp40525_c0 | - |
| Cc-Ven17 | 10.97 (L)/1 | Extracellular superoxide dismutase 3 | 172 (Y) | 2.00e−56; AET83769.1/AET83767.1; | comp40765_c0 | KU663632 |
| Cc-Ven18 | 466.16 (M)/1 | Kazal-type proteinase inhibitor | 120 (Y) | 3.00e−22; BAO48212.1; | comp23198_c0 | KU663633 |
| Cc-Ven19 | 4970.74 (H)/16 | Serine protease inhibitor (Serpin) | 406 (Y) | 3.00e−71; XP_008201843.1 | comp23147_c0 | KU663634 |
| Cc-Ven20 | 89.09 (L)/10 | Immunoevasive protein-2 | 320 (NC) | 1.00e−62; BAB72015.1 | comp39249_c0 | KU663635 |
| Cc-Ven21 | 103.23 (M)/7 | Immunoevasive protein-2 | 180 (NC) | 5.00e−13; BAB72015.1 | comp42303_c0 | KU663636 |
| Cc-Ven22 | 377.40 (M)/21 | Calreticulin | 403 (Y) | 0; AAN73309.1; | comp11089_c0 | KU663637 |
| Cc-Ven23 | 11187.79 (H)/34 | Venom protein Ci-48a | 384 (NC) | 7.00e−14; CBM69271.1; | comp39158_c0 | KU663638 |
| Cc-Ven24 | 1862.61 (H)/5 | Icarapin-like precursor | 227 (Y) | 2.00e−20; NP 001012431.1; | comp44327_c0 | KU663639 |
| Cc-Ven25 | 24.06 (L)/5 | Corticotropin-releasing factor-binding protein | 327 (Y) | 3.00e−95; XP_003692566.1; | comp25125_c0 | KU663640 |
| Cc-Ven26 | 36.45 (L)/8 | Vascular endothelial growth factor receptor 2 | 231 (Y) | e−13; EFN76191.1; | comp23754_c0 | KU663641 |
| Cc-Ven27 | 36.81 (L)/11 | Mesencephalic astrocyte-derived neurotrophic factor | 842 (Y) | 3.82e−66; BAM18078.1; | comp10689_c0 | - |
| Cc-Ven28 | 59.91 (L)/1 | DnaJ homolog subfamily C member 10-like | 2650 (Y) | 0; XP_001606269.2; | comp32038_c0 | - |
| Cc-Ven29 | 64.12 (L)/3 | DnaJ homolog subfamily B member 11-like | 1665 (Y) | 0; XP_624603.2; | comp45528_c0 | - |
| Cc-Ven30 | 67.36 (L)/6 | Endoplasmic reticulum protein ERp29 | 987 (Y) | 3.36e−103; EGI59372.1; | comp32086_c0 | - |
| Cc-Ven31 | 92.63 (L)/1 | Endoplasmic reticulum resident protein 44 | 1350 (Y) | 0; XP_624571.2; | comp11316_c0 | - |
| Cc-Ven32 | 101.69 (M)/52 | Heat shock 70 kDa protein | 2840 (Y) | 0; EFN61604.1; | comp35875_c0 | - |
| Cc-Ven33 | 72.01 (L)/4 | Unknown | 357 (Y) | - | comp38220_c0 | KU663642 |
| Cc-Ven34 | 84.75 (L)/1 | Unknown | 132 (Y) | - | comp44992_c0 | KU663643 |
| Cc-Ven35 | 270.62 (M)/4 | Unknown | 516 (Y) | - | comp23465_c0 | KU663644 |
| Cc-Ven36 | 1465.76 (H)/20 | Unknown | 291 (Y) | - | comp39041_c2 | KU663645 |
| Cc-Ven37 | 1659.20 (H)/43 | Unknown | 1033 (Y) | comp39175_c0 | KU663646 | |
NC means that prediction of secretion could not be performed due to the incompleteness of the sequence and Y represents the deduced amino acid sequences with predicted signal peptides. L, M, and H represent low, medium and high abundance of unigene expression levels, respectively, according to the RPKM values.
Figure 3qPCR results showing the mRNA abundance levels of selected unigenes in indicated female tissues. (A) Cc-Ven1, Serine protease; (B) Cc-Ven4, Tolloid-like protein; (C) Cc-Ven10, Phospholipase A1; (D) Cc-Ven12, Chitooligosaccharidolytic β-N-acetylglucosaminidase; (E) Cc-Ven14, FK506-binding protein 14; (F) Cc-Ven17, Extracellular superoxide dismutase 3; (G) Cc-Ven19, Serine protease inhibitor (Serpin); (H) Cc-Ven20, Immunoevasive protein-2; (I) Cc-Ven21, Immunoevasive protein-2; (J) Cc-Ven22, Calreticulin; (K) Cc-Ven25, Corticotropin-releasing factor-binding protein.
Figure 4(A) Multiple sequence alignment of CUB domains of serine proteases. The paired numbers above the conserved Cys residues indicate two pairs of the disulfide linkages (B) Multiple alignment of the catalytic domains of arthropod serine proteases. The amino acids of the catalytic triad are in the red boxes and the determinants of the specificity pocket are in the purple boxes. The paired numbers above conserved Cys residues indicate the disulfide linkage in the catalytic domain. Cysteines involved in interdomain disulfide bonds are in the blue boxes. The two unique Cys residues in most group II proteases are shown in the green boxes. The amino acid prior to the proteolytic activation site (arrow) is included at the beginning of each sequence. The sequence analyses of catalytic domains were mainly based on [50]. Multiple alignment was performed using ClustalX2. Protein full names and sequence accession numbers are provided in Supplementary Table S4.
Figure 5Phylogenetic tree built based on an alignment of the catalytic and protease-like domains of serine proteases and serine protease homologs. Maximum likelihood unrooted tree is based on deduced amino acid sequences of different catalytic and protease-like domains and constructed using PhylML with Smart Model Selection [58]. The best model is LG+G+I. Red arrowheads at nodes indicate bootstrap values higher than 50%. Circles with different colors represent the venom serine proteases from different parasitoid wasps (red: Cotesia chilonis; blue: Nasonia vitripennis; green: Pteromalus puparum). The full names of the proteins and accession numbers of the sequences are listed in Supplementary Table S4.
Figure 6(A) Multiple alignment based on parts of catalytic domains of selected astacins. The alignment was performed using ClustalX2. Arrows in the red box point to the astacin signature sequence and blue box indicates the Met-turn; (B) Phylogeny of proteins containing Astacin domains. The maximum likelihood unrooted tree is based on deduced amino acid sequences of different Astacin domains and constructed using PhylML with Smart Model Selection [58]. The best model is LG+G+I. Bootstrap values higher than 50% are indicated at each corresponding node. Red circles indicate two astacin-like venom proteins from Cotesia chilonis. Purple and blue circles indicate astacin-like venom proteins identified from Nematostella vectensis and Loxosceles intermedia (Araneae: Sicariidae), respectively. BMP1/Tolloid subgroup of the Astacin family is shaded by yellow. The full names of the proteins and accession numbers of the sequences are listed in Supplementary Table S4.